Description
Ginkgolide AB is a mixture of ginkgolides A and B, terpene lactones found in Ginkgo. This mixture typically contains >90% A and >5% B.
Ginkgolide AB
Product ID G3356
Cas No.
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Purity | ≥98% |
|---|---|
| Solubility | Insoluble in water. Soluble in DMSO, acetone, ethanol, ethyl acetate, methanol. |
| Appearance | White Crystal Powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Zhang Y, Zhao Y, Zhang J, et al. Quantitative proteomics reveals neuroprotective mechanism of ginkgolide B in Aβ1-42-induced N2a neuroblastoma cells. J Integr Neurosci. 2023 Feb 14;22(2):33. PMID: 36992579
Wang L, Zhao Y, Su Z, et al. Ginkgolide A targets forkhead box O1 to protect against lipopolysaccharide-induced septic cardiomyopathy. Phytother Res. 2023 Mar 18. doi: 10.1002/ptr.7802. PMID: 36932920
Chen J, Ou Z, Gao T, et al. Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy. Biomed Pharmacother. 2022 Dec;156:113953. PMID: 36411664
Zhu J, Jin Z, Yang L, et al. Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice. Pharmacol Res. 2022 Jun;180:106240. PMID: 35513225
Li J, Chen J, Yang Y, et al. Ginkgolide A attenuates sepsis-associated kidney damage via upregulating microRNA-25 with NADPH oxidase 4 as the target. Int Immunopharmacol. 2021 Jun;95:107514. PMID: 33677255